|
HS Code |
532972 |
| Product Name | Methyl 4-Bromoindole-2-Carboxylate |
| Cas Number | 3939-18-6 |
| Molecular Formula | C10H8BrNO2 |
| Molecular Weight | 254.08 |
| Appearance | Off-white to pale yellow solid |
| Melting Point | 154-158°C |
| Purity | Typically >97% |
| Solubility | Soluble in organic solvents like DMSO and methanol |
| Smiles | COC(=O)c1[nH]c2ccc(Br)cc2c1 |
| Inchi | InChI=1S/C10H8BrNO2/c1-14-10(13)9-7-4-2-3-6(11)5-8(7)12-9/h2-5,12H,1H3 |
| Synonyms | 4-Bromo-1H-indole-2-carboxylic acid methyl ester |
| Storage Temperature | 2-8°C |
As an accredited Methyl 4-Bromoindole-2-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Methyl 4-Bromoindole-2-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Few molecules draw as much attention in the research laboratory as Methyl 4-Bromoindole-2-Carboxylate. Its structure brings together a bromine atom and a methyl ester on the indole skeleton, which opens up whole avenues for chemical synthesis and pharmaceutical development. I've spent years in the lab handling countless reagents, but this compound stays memorable for its adaptability and the way it takes center stage in so many reactions where precision matters.
Unlike generic indole derivatives, Methyl 4-Bromoindole-2-Carboxylate bears the chemical formula C10H8BrNO2. The indole core, decorated with a bromine atom at the fourth position, doesn’t just change its reactivity—it brings about new opportunities for constructing more complex molecules. The methyl ester at the second position eases purification and improves yields in transformations that would strand other molecules in low-yield purgatory. These structural tweaks aren’t just academic. In my experience, they mean the difference between an experiment that offers real data and one that leaves you with hours of troubleshooting.
In pharmaceutical research, indole building blocks have shaped many breakthroughs in CNS drugs, anticancer compounds, and anti-inflammatory agents. Methyl 4-Bromoindole-2-Carboxylate carves a niche as a scaffold from which to branch out, thanks to that bromine. Testing halogenated indoles can tip the scales toward new bioactivity—a bromine atom confers increased lipophilicity and metabolic stability in the right context. You won’t often see the same pattern with the more basic indole-2-carboxylates, since the added halogen brings both steric bulk and electron-withdrawing power.
I’ve worked in teams designing kinase inhibitors, and we looked for ways to efficiently install new side chains. The bromo group acts almost like a calling card for Suzuki-Miyaura and Buchwald-Hartwig cross-couplings. Once it’s on the molecule, attaching aryls or amines in the next step becomes practical, not a multi-day struggle. There’s a big difference between theory and actual benchtop wrangling with finicky reactants. Having a site open for reliable palladium-catalyzed coupling saves time, money, and nerves—qualities every medicinal chemist values.
In research, small tweaks can save months of work down the line. Generic indole-2-carboxylates might react, but many lack the versatility needed for cross-coupling chemistry. Dodging solubility or purification headaches lets you focus on new targets, not getting stuck in endless optimization.
A methyl ester usually offers a smoother ride than ethyl or tert-butyl groups, especially for hydrolysis or amidation. Methyl 4-Bromoindole-2-Carboxylate dissolves readily in most polar organic solvents and silica filtration strips away impurities without elaborate tricks. In the real world, that means fewer do-overs and more time moving forward.
I appreciate reagents that let me chart out a pathway and stick to it. You don’t have to gamble with reaction times or wonder if inconsistencies will slow things down. That reliability contributes to reproducible research, which builds trust in the data. As someone who has run parallel syntheses for SAR libraries, shaving a few hours off each round means everything when deadlines approach.
Medicinal chemists often seek indole motifs because of their presence in natural products, hormones, and commercial drugs. The 4-bromo function of this compound isn’t just for looks—it’s a practical asset that enables diverse modifications not possible with unsubstituted versions. In my view, this advantage matters most when teams aim for structural diversity in a compound library. The methyl ester takes on extra significance, too, since switching esters or moving to amides often comes near the end of a synthetic sequence. Researchers dealing with metabolic studies can directly access carboxylic acid derivatives for further profiling, or use the methyl group as a handle for late-stage diversification.
Unlike more common indole carboxylates, this compound gives researchers flexibility at the cross-coupling step. You can swap out the bromo for groups as varied as aromatic rings, heterocycles, or even simple alkyls—each change might unlock a different biological response. Having the right substitution pattern at your disposal increases the chance of hitting on a productive molecular scaffold.
Working with other indole esters can demand more rounds of protection and deprotection, adding to tedium and risk of error. In my hands, using Methyl 4-Bromoindole-2-Carboxylate sidesteps many wasted steps. The bromine atom adds useful reactivity for chemists skilled in transition metal catalysis, while standard indole esters lack this reactive anchor.
Researchers often compare this product with unsubstituted Methyl Indole-2-Carboxylate or its chloro- or fluoro-substituted cousins. Each halogen changes the reactivity profile. Bromine offers an optimal balance: reactive enough for palladium chemistry, less hazardous than iodine, and less volatile than fluorine. You avoid the pitfalls of overly inert or unstable intermediates. I’ve noticed this pattern consistently, especially in late-stage functionalization. Unless there is a specific need for lighter or heavier halogens, the bromo group becomes the preferred option for most robust synthetic steps.
Purity and ease of handling also distinguish this compound from bulkier esters. A methyl group’s size works well with automated liquid handlers, a real plus in industry settings. Tert-butyl esters or long-chain alkyl esters tend to complicate things with oily residues or unexpected retention times on chromatography, based on my own attempts to automate parallel synthesis.
Authentic research doesn’t take place in a vacuum. Chemical purity, melting point, and stability during storage make all the difference. High-grade Methyl 4-Bromoindole-2-Carboxylate usually presents as a pale solid. In well-sealed kilolab bottles under argon, it holds up for months. I’ve pulled 95+% pure samples from storage and put them straight into coupling reactions without second guessing the batch integrity.
Beyond performance on the bench, consistent lot analysis gives peace of mind. Chromatography confirms low impurity loads and batch records from reputable suppliers document synthetic routes that avoid problematic byproducts. Over my career I have had to reject bulk indoles from less rigorous suppliers due to residual halogenated byproducts or inconsistent melting points. Paying attention to such specs avoids project delays and supports regulatory compliance, which takes increasing importance in fields such as drug development and academic research.
Loading this compound into a cross-coupling reaction never feels like a roll of the dice. Its bromo group gives reliable yields for Suzuki, Stille, and Sonogashira couplings. The methyl ester survives most coupling conditions I’ve tried, only giving way when you hit it with strong bases or heating in hydrolytic conditions. For N-alkylation or amide formation, the indole NH and ester handle play well with standard protocols.
Having worked alongside colleagues focused on fragment-based drug discovery, I’ve seen this compound become a standard choice due to these properties. Its moderate molecular weight and synthetic tractability place it near the sweet spot for library construction. Adding diversity at the 4-position with bromo makes fragment expansion easy without branching into unpredictable chemistry.
A good reagent won’t just tick off boxes on a spec sheet. It has to deliver under pressure, whether that’s delivering quick SAR data or allowing scale-up for a new lead. I have run multi-gram reactions for external collaborators who value straightforward isolation and robust yields—and this compound holds up under both small- and large-scale runs.
I once joined a project seeking new leads against a troublesome kinase target. Standard indole building blocks kept offering weak or uninformative hits, but the introduction of a 4-bromo substituent turned the tide. Using methyl 4-bromoindole-2-carboxylate let us make dozens of analogues by modifying the 4-position, ultimately uncovering strong hits. With more basic compounds, we would have wasted weeks navigating cumbersome synthetic routes.
In laboratory settings, halogenated aromatics can trigger safety audits, so handling matters. My experience tells me methyl esters tend to have lower volatility than comparable free acids or phenols, reducing exposure risk. Standard lab PPE and efficient fume hoods are effective with this compound, as is proper labeling and segregation. I’ve found that responsible waste management, solvent recycling, and scaled-down pilot runs minimize environmental footprint.
The compound’s solid state and relatively high melting point mean spills are less likely to vaporize and pose inhalation risk. Chemical suppliers with strong track records usually offer solid documentation for safe usage protocols, supporting compliance with safety and environmental regulations at the institutional level.
One persistent headache for researchers is low-yielding indole couplings, especially at late stages of a synthesis. A bromo substituent at the 4-position on indole creates a functional handle for transformations via metal catalysis. My team has leveraged this reactivity to install diverse substituents, producing richer libraries for screening programs without requiring a patchwork of protection and deprotection steps.
Another recurring issue involves harsh deprotection protocols damaging sensitive scaffolds. Methyl ester groups resist many reaction conditions but come off cleanly under classic saponification conditions with aqueous sodium hydroxide or lithium hydroxide. This advantage keeps downstream steps uncomplicated, especially helpful in scaling up milligram results to tens of grams.
Where other esters fail to dissolve or risk premature hydrolysis, methyl esters keep reactions manageable. For high-throughput screening, solubility matters as much as reactivity. Taking the practical route, I’ve preferred this compound over bulkier or more labile alternatives due to the reliable performance in DMSO, DMF, and even acetonitrile-based systems.
Today’s drug discovery pipeline demands quick, reliable access to new chemical space. Methyl 4-Bromoindole-2-Carboxylate streamlines synthetic routes, which empowers scientists to tackle more targets and iterate faster. Junior team members in my labs notice the difference as projects progress without the distraction of unexpected reactivity or purification hiccups.
I’ve seen academic researchers, CRO teams, and industry veterans use this compound as a backbone for synthesizing dozens of small-molecule libraries. Such widespread, real-world adoption speaks volumes. In an environment where funding and publication pressures tally every lost week, using a proven indole building block simplifies critical steps.
Across dozens of projects, Methyl 4-Bromoindole-2-Carboxylate has proven a robust, high-performing option for modern chemists aiming at pharmaceutical synthesis and molecular assembly. The balance of reliable reactivity, straightforward purification, solid regulatory documentation, and practical flexibility differentiates it from less specialized indole derivatives. This compound enables confident progress on both discovery and development fronts, supported by hands-on results and decades of evolving synthetic strategies.
Where other building blocks leave researchers managing limitations, this one keeps efforts focused on real innovation. For anyone committed to exploring new pharmacophores, optimizing SAR, or pushing the envelope in chemical biology, Methyl 4-Bromoindole-2-Carboxylate demonstrates its value not on paper, but at the benchtop, day after day.